[go: up one dir, main page]

WO2012163831A1 - Novel hydroformylation process - Google Patents

Novel hydroformylation process Download PDF

Info

Publication number
WO2012163831A1
WO2012163831A1 PCT/EP2012/059841 EP2012059841W WO2012163831A1 WO 2012163831 A1 WO2012163831 A1 WO 2012163831A1 EP 2012059841 W EP2012059841 W EP 2012059841W WO 2012163831 A1 WO2012163831 A1 WO 2012163831A1
Authority
WO
WIPO (PCT)
Prior art keywords
trans
catalytic system
rhodium complex
xylylphosphino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/059841
Other languages
French (fr)
Inventor
Dieter Arlt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Umicore AG and Co KG
Original Assignee
Umicore AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102011102666A external-priority patent/DE102011102666A1/en
Application filed by Umicore AG and Co KG filed Critical Umicore AG and Co KG
Priority to US14/122,153 priority Critical patent/US9108912B2/en
Priority to EP12723505.9A priority patent/EP2714699A1/en
Priority to JP2014511904A priority patent/JP2014524889A/en
Priority to CN201280025524.5A priority patent/CN103562213A/en
Priority to BR112013030262A priority patent/BR112013030262A2/en
Publication of WO2012163831A1 publication Critical patent/WO2012163831A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505Asymmetric hydroformylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5027Polyphosphines
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • B01J31/2414Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04Saturated ethers
    • C07C43/13Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1788Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • C07F15/008Rhodium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • C07C2531/24Phosphines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring

Definitions

  • the present invention relates to a process for hydro formylating allyl alcohol in order to produce 4-hydroxybutyraldehyde.
  • the present invention provides a process for producing 4-hydroxybutyraldehyde, characterized in that allyl alcohol dissolved in polar solvents is reacted with CO and H 2 in the presence of a catalytic system which is formed from a rhodium complex and a cyclobutane ligand which contains at least two trans-coordinated 1,3-dialkylphenyl- phosphinomethyl groups, with the exclusion of catalysts which contain an aliphatic, aliphatic or cycloaliphatic phosphine as ligand.
  • a catalytic system which is formed from a rhodium complex and a cyclobutane ligand which contains at least two trans-coordinated 1,3-dialkylphenyl- phosphinomethyl groups
  • Trans-l,2-(l,3-dialkylphenylphosphinomethyl)cyclobutanes which are used as ligands present invention have the formula [A]
  • R 1 is alkyl, preferably methyl, ethyl or propyl
  • R 2 is H or an alkoxy group
  • R 3 and R 4 independently of one another, are H, CH 2 OR 1 , CH 2 0-aralkyl, CH 2 OH, CH 2 -[P(3,5-R 1 ,R 1 -4-R 2 -phenyl) 2 ] or
  • [A] is an all-trans-cyclobutane derivative.
  • An additional aspect of the invention is the use of novel catalysts of the formula [A] which permit different embodiments of the process according to the invention.
  • hydro formylation according to the invention in polar solvents allows lipophilic catalysts of the formula [A] to be separated off by extraction with hydrophobic solvents, and the catalyst to be returned to the first process stage.
  • Novel hydrophilic catalyst systems of the formula [A] with polyether groups can be used in membrane reactors and thus allow the process products to be separated off continuously after the hydroformylation.
  • the process according to the invention differs with respect to hitherto described processes for producing HBA by virtue of the exclusion of catalysts which contain ligands of the formulae PR'3, where R' is an aliphatic, araliphatic or cycloaliphatic radical. Catalysts of this type hydrogenate a considerable fraction of the allyl alcohol used to give undesired byproducts (see USP 7,655,821 Bl).
  • diphosphines of the DIOP series such as e.g. 2,3-0-isopropylidene-2,3-dihydroxy-l,4-bis[bis(3,5-dimethylphenylphosphino]butane; (see WO2010/132087).
  • polar solvents used in the process according to the invention are not reactive toward the products of the hydroformylation. In contrast to the solvents used in known processes, (see e.g. WO2010/132087), they are soluble in significant proportions, and sometimes also completely, in water.
  • Polar solvents which may be mentioned are, for example, ethanol, propanol, n-butanol, isobutanol, 1,4-butanediol and polyethers of the formula CH30-(-CH 2 -CH 2 -0) n -H with a molecular weight > 2000.
  • the hydroformylation takes place under reaction conditions known per se in the temperature range from 20 to 120°C and in a pressure range from 2-20 bar. The optimum performance is ascertained by appropriate preliminary experiments depending on the predetermined equipment.
  • the molar ratio of CO:H 2 is ca. 1 : 1, but can vary considerably depending on the embodiment.
  • the reaction time is 0.5-4 hours.
  • the allyl alcohol concentration is 5-50%, preferably 10-25%, based on the solvent or solvent mixture.
  • HBA hydrogenated in a manner known per se to give the corresponding dihydroxy compounds, and fractional distillation of the crude product gives the desired 1,4-butanediol in pure form.
  • Ni, Co, Ru, Pt, Pd, Cu, Zn and Cr catalysts can be used for the hydrogenation.
  • Raney® Ni catalysts are particularly preferably used.
  • the hydrogenation is generally carried out at temperatures of 60-200°C and in the pressure range 15-70 bar.
  • H-7b 3.18 ( . 2H, H-5&, H-3ai; 2 ,98 (rn, 2H » H-5b.
  • LiP(3,5-xylyl) 2 LiP(3,5-xylyl) 2 .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

The present invention relates to a process for producing 4-hydroxybutyraldchyde, characterized in that allyl alcohol dissolved in polar solvents is reacted with CO and H2 in the presence of a catalytic system which is formed from a rhodium complex and a cyclobutane ligand which contains at least two trans-coordinated 1,3-dialkylphenyl- phosphinomethyl groups, with the exclusion of catalysts which contain an aliphatic, araliphatic or cycloaliphatic phosphine as ligand. In which R1 is alkyl, preferably methyl, ethyl or propyl R2 is H or an alkoxy group, R3 and R4 independently of one another, are H, CH2OR1, CH2O-aralkyl, CH2OH, CH2-[P(3,5-R1,R1-4-R2-phenyl)2] or CH2O-(CH2-CH2-O)m-H where m is a number from 1 to 1000.

Description

NOVEL HYDROFORMYLATION PROCESS
The present invention relates to a process for hydro formylating allyl alcohol in order to produce 4-hydroxybutyraldehyde.
BACKGROUND OF THE INVENTION
The hydroformylation of allyl alcohol is known and is utilized industrially (see e.g. USP 4,064,145; USP 4,215,077; USP 4,238,419; USP 4,678,857; USP 5,290,743). Allyl alcohol is reacted in these processes with CO/H2 gas mixtures, giving 4-hydroxybutyraldehyde (HBA). Following distillative removal of undesired by-products, HBA is hydrogenated in a known manner to give 1,4-butanediol (BDO).
A disadvantage of this mode of production is the formation of undesired by-products. In particular, as well as the desired linear product, the isomeric branched product 3-hydroxy-2- methylpropionaldehyde (HMPA) and other C3 by-products such as n-propanol and propionaldehyde are formed. This adversely affects the economic viability of the process.
The present invention provides a process for producing 4-hydroxybutyraldehyde, characterized in that allyl alcohol dissolved in polar solvents is reacted with CO and H2 in the presence of a catalytic system which is formed from a rhodium complex and a cyclobutane ligand which contains at least two trans-coordinated 1,3-dialkylphenyl- phosphinomethyl groups, with the exclusion of catalysts which contain an aliphatic, aliphatic or cycloaliphatic phosphine as ligand. DETAILED DESCRIPTION OF THE INVENTION
Trans-l,2-(l,3-dialkylphenylphosphinomethyl)cyclobutanes which are used as ligands present invention have the formula [A]
Figure imgf000003_0001
in which
R1 is alkyl, preferably methyl, ethyl or propyl
R2 is H or an alkoxy group,
R3 and R4, independently of one another, are H, CH2OR1, CH20-aralkyl, CH2OH, CH2-[P(3,5-R1,R1-4-R2-phenyl)2] or
CH20-(CH2-CH2-0)m-H where m is a number from 1 to 1000.
Preferably [A] is an all-trans-cyclobutane derivative.
An additional aspect of the invention is the use of novel catalysts of the formula [A] which permit different embodiments of the process according to the invention.
Usually, the hydro formylation of allyl alcohol with known catalysts is carried out in homogeneous phase. After the reaction, HBA, HMPA and other by-products are separated off from the catalyst by extraction with water.
The hydro formylation according to the invention in polar solvents allows lipophilic catalysts of the formula [A] to be separated off by extraction with hydrophobic solvents, and the catalyst to be returned to the first process stage. Novel hydrophilic catalyst systems of the formula [A] with polyether groups can be used in membrane reactors and thus allow the process products to be separated off continuously after the hydroformylation.
The process according to the invention differs with respect to hitherto described processes for producing HBA by virtue of the exclusion of catalysts which contain ligands of the formulae PR'3, where R' is an aliphatic, araliphatic or cycloaliphatic radical. Catalysts of this type hydrogenate a considerable fraction of the allyl alcohol used to give undesired byproducts (see USP 7,655,821 Bl).
By contrast, in the process according to the invention, instead of catalysts which contain a cyclo butane ligand which has at least two trans-coordinated 1,3-dialkylphenylphosphino- methyl groups, it is also possible to use diphosphines of the DIOP series, such as e.g. 2,3-0-isopropylidene-2,3-dihydroxy-l,4-bis[bis(3,5-dimethylphenylphosphino]butane; (see WO2010/132087).
However, preference is given to catalysts of the cyclobutane series, which allow more favorable HBA:HMPA- proportions to be achieved.
The polar solvents used in the process according to the invention are not reactive toward the products of the hydroformylation. In contrast to the solvents used in known processes, (see e.g. WO2010/132087), they are soluble in significant proportions, and sometimes also completely, in water.
Polar solvents which may be mentioned are, for example, ethanol, propanol, n-butanol, isobutanol, 1,4-butanediol and polyethers of the formula CH30-(-CH2-CH2-0)n-H with a molecular weight > 2000.
The hydroformylation takes place under reaction conditions known per se in the temperature range from 20 to 120°C and in a pressure range from 2-20 bar. The optimum performance is ascertained by appropriate preliminary experiments depending on the predetermined equipment. The molar ratio of CO:H2 is ca. 1 : 1, but can vary considerably depending on the embodiment.
The reaction time is 0.5-4 hours. At the start of the reaction, the allyl alcohol concentration is 5-50%, preferably 10-25%, based on the solvent or solvent mixture.
HBA (and HMPA) are hydrogenated in a manner known per se to give the corresponding dihydroxy compounds, and fractional distillation of the crude product gives the desired 1,4-butanediol in pure form. Ni, Co, Ru, Pt, Pd, Cu, Zn and Cr catalysts can be used for the hydrogenation. Raney® Ni catalysts are particularly preferably used. The hydrogenation is generally carried out at temperatures of 60-200°C and in the pressure range 15-70 bar.
The examples below illustrate the process according to the invention:
Example 1
Preparation of a novel catalyst which is used in the process according to the invention: a) Preparation of a novel intermediate from known all-trans- 1,2,3, 4-(hydroxy- methyl)cyclo butane :
88 mg (0.5 mmol) of all-trans-l,2,3,4-(hydroxymethyl)cyclobutane were dissolved in 3 ml of anhydrous pyridine and, at 0°C, 251 mg (0.9 mmol) of trityl chloride were added with intense stirring. The reaction mixture was kept at 0°C overnight with stirring. Then, it was added to 10 ml of water and extracted with ethyl acetate (3x5 ml), then dried with MgSC^ and evaporated to dryness in a rotary evaporator.
The crude product was separated off by chromatography (silica gel). (Eluent: ethyl acetate :hexane l :3→2:3→ethyl acetate :methanol 95:5).
The main product obtained was 114 mg (34% of theory) of all-trans-l,2-(hydroxymethyl)- 3,4-(trityloxymethyl)cyclo butane. CDC 7.1 5-7.4 (m, 1 5H, Ar); 3.86 (m, 2R H-6a , H-7a):
H-7b); 3.18 ( . 2H, H-5&, H-3ai; 2 ,98 (rn, 2H» H-5b. H- H- 1 , H-2, H-3 ami H-4);
143.95; 128.60; 127.79: 126,98, 86.84; 66.24 ; 65.71 : 43.68;
Figure imgf000006_0001
b) In a manner known per se, this compound was tosylated and reacted with
LiP(3,5-xylyl)2.
Example 2
Hydroformylation corresponding to the process according to the invention:
In 4 ml of dried and degassed tert-butyl methyl ether, 16 mmol of all-trans-l,2,3,4-(3,5- xylylphosphinomethyl)cyclo butane are reacted under argon with [Rh(CO)2(acac)] (8 mmol).
The resulting solution is injected into an autoclave under argon and flushed with a CO:H2-l:l mixture. Via a side arm, a solution of 1 ml of allyl alcohol in 15 ml of ethanol is then added and the reaction is carried out at a pressure of 40 bar and a temperature of 120°C. This gives 97% of theory of HBA + HMPA in a ratio of ca. 14: 1.

Claims

1. A process for producing 4-hydroxybutyraldehyde, characterized in that allyl alcohol is reacted in polar solvents with CO and ¾ in the presence of a catalytic system which is formed from a rhodium complex and a cyclobutane ligand which comprises at least two trans-coordinated 1,3-dialkylphenylphosphinomethyl groups, with the exclusion of catalysts which contain an aliphatic, araliphatic or cycloaliphatic phosphine as ligand.
2. The process as claimed in claim 1, characterized in that a catalytic system is used which is formed from a rhodium complex and all-trans-l,2,3,4-(3,5-xylylphosphino- methyl)cyclo butane.
3. The process as claimed in claim 1, characterized in that a catalytic system is used which is formed from a rhodium complex and trans-l,2-(3,5-xylylphosphino- methylcyclo butane.
4. The process as claimed in claim 1, characterized in that a catalytic system is used which is formed from a rhodium complex and all-trans-l,2,3-(3,5-xylylphosphino- methyl)-4-(methoxymethyl)cyclo butane.
5. The process as claimed in claim 1, characterized in that a catalytic system is used which is formed from a rhodium complex and all-trans-l,2-(3,5-xylylphosphino- methyl)-3,4-bis(trityloxymethyl)cyclo butane.
6. The process as claimed in claim 1, characterized in that alcohols in which water is soluble to at least 2% parts by weight, preferably > 5%, are used as polar solvents.
7. The process as claimed in claim 1, characterized in that polyethers which are water- soluble and whose molecular weight is > 2000 are used as polar solvents.
8. The catalyst used in claim 2.
9. The catalyst used in claim 4.
The catalyst used in claim 5.
11. All-trans- 1 ,2-(hydroxymethyl)-3 ,4-(trityloxymethyl)cyclo butane.
The process as claimed in claim 1 , characterized in that a catalytic system is used which is formed from a rhodium complex and all-trans-l,2,3-(3,5-xylylphosphino- methyl)-4-(hydroxymethyl)cyclo butane.
The process as claimed in claim 1 , characterized in that a catalytic system is used which is formed from a rhodium complex and all-trans-l,2,3-(3,5-xylylphosphino- methyl)-4-CH2-(0-CH2-CH2-0)m-H, where m is a number from 1-1000.
The process as claimed in claim 13, characterized in that the hydro formylation takes place in a membrane reactor.
The process as claimed in claim 1 , characterized in that the catalyst used is separated off from the reaction mixture, optionally after adding water, by extraction with hydrophobic solvents and is reused.
The process as claimed in claim 1 , characterized in that a catalytic system is used which is formed from a rhodium complex and all-trans-l,2,3,4-(3,5-xylylphosphino- methyl)cyclo butane.
The catalyst used in claim 16.
18. The process as claimed in claim 1 , characterized in that the catalytic system used in claim 16 is separated off, optionally after adding water, with hydrophobic solvents and is reused.
PCT/EP2012/059841 2011-05-27 2012-05-25 Novel hydroformylation process Ceased WO2012163831A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US14/122,153 US9108912B2 (en) 2011-05-27 2012-05-25 Hydroformylation process
EP12723505.9A EP2714699A1 (en) 2011-05-27 2012-05-25 Novel hydroformylation process
JP2014511904A JP2014524889A (en) 2011-05-27 2012-05-25 Novel hydroformylation process
CN201280025524.5A CN103562213A (en) 2011-05-27 2012-05-25 Novel hydroformylation process
BR112013030262A BR112013030262A2 (en) 2011-05-27 2012-05-25 hydroformylation process

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102011102666.9 2011-05-27
DE102011102666A DE102011102666A1 (en) 2011-05-27 2011-05-27 Producing 4-hydroxybutyraldehyde, comprises reacting allyl alcohol with carbon monoxide and hydrogen in polar solvent, in presence of catalytic system, which is formed from rhodium complex and cyclobutane ligand
DE102011110621.2 2011-08-16
DE102011110621 2011-08-16

Publications (1)

Publication Number Publication Date
WO2012163831A1 true WO2012163831A1 (en) 2012-12-06

Family

ID=46149490

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2012/059850 Ceased WO2012163837A1 (en) 2011-05-27 2012-05-25 Ligands and catalyst systems for hydroformylation processes
PCT/EP2012/059841 Ceased WO2012163831A1 (en) 2011-05-27 2012-05-25 Novel hydroformylation process

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/059850 Ceased WO2012163837A1 (en) 2011-05-27 2012-05-25 Ligands and catalyst systems for hydroformylation processes

Country Status (9)

Country Link
US (2) US9108912B2 (en)
EP (2) EP2714699A1 (en)
JP (2) JP2014520089A (en)
CN (2) CN103748102A (en)
BR (2) BR112013029852A2 (en)
CA (1) CA2835744A1 (en)
RU (1) RU2013157751A (en)
TW (1) TW201306939A (en)
WO (2) WO2012163837A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791305B2 (en) 2011-05-27 2014-07-29 Umicore Ag & Co. Kg Ligands and catalyst systems for hydroformylation processes
EP3181546A1 (en) 2015-12-16 2017-06-21 Evonik Degussa GmbH Method of double carbonylation of allylic alcohols in order to form corresponding diesters
US10807934B1 (en) 2019-05-31 2020-10-20 Lyondell Chemical Technology, L.P. High linear selectivity ligand for allyl alcohol hydroformylation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3530644B1 (en) 2018-02-26 2022-11-02 Lyondell Chemical Technology, L.P. Improving rhenium catalysts for glycerin to allyl alcohol conversion
CN112457165A (en) * 2019-09-06 2021-03-09 南京延长反应技术研究院有限公司 Reinforcing system and process for preparing 1, 4-butanediol by allyl alcohol hydrogenation
CN110975941B (en) * 2019-12-17 2022-08-05 万华化学集团股份有限公司 Hydroformylation reaction catalyst composition and method for preparing aldehyde through propylene hydroformylation reaction
CN113061149B (en) * 2021-03-29 2022-04-22 万华化学集团股份有限公司 Preparation method of interchelated ligand, hydroformylation catalyst and dihydric alcohol
CN116440953B (en) * 2023-02-28 2024-11-15 中海油天津化工研究设计院有限公司 Oxo catalyst and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121194A1 (en) * 2007-04-02 2008-10-09 Lyondell Chemical Technology, L.P. Hydroformylation process

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064145A (en) 1975-10-20 1977-12-20 Celanese Corporation Production of tetrahydrofuran
US4215077A (en) 1978-02-09 1980-07-29 Kuraray Co., Ltd. Hydroformylation of olefins
FR2428021A1 (en) 1978-06-05 1980-01-04 Kuraray Co HYDROFORMYLATION OF OLEFINIC COMPOUNDS
US4678857A (en) 1986-03-31 1987-07-07 Texaco Inc. Process for separation of product resulting from hydroformylation
US5290743A (en) 1993-03-22 1994-03-01 Arco Chemical Technology L.P. Process for regenerating a deactivated rhodium hydroformylation catalyst system
US7655821B1 (en) 2008-11-25 2010-02-02 Lyondell Chemical Technology, L.P. Direct hydrocarbonylation process
US20100292514A1 (en) * 2009-05-13 2010-11-18 White Daniel F Hydroformylation process
JP2014520089A (en) 2011-05-27 2014-08-21 ウミコレ・アーゲー・ウント・コ・カーゲー Ligands and catalyst systems for hydroformylation processes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121194A1 (en) * 2007-04-02 2008-10-09 Lyondell Chemical Technology, L.P. Hydroformylation process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
INE I. F. BOOGAERTS ET AL: "High chemo and regioselective formation of alcohols from the hydrocarbonylation of alkenes using cooperative ligand effects", CHEMICAL COMMUNICATIONS, vol. 46, no. 13, 1 January 2010 (2010-01-01), pages 2194, XP055031789, ISSN: 1359-7345, DOI: 10.1039/b927236d *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791305B2 (en) 2011-05-27 2014-07-29 Umicore Ag & Co. Kg Ligands and catalyst systems for hydroformylation processes
EP3181546A1 (en) 2015-12-16 2017-06-21 Evonik Degussa GmbH Method of double carbonylation of allylic alcohols in order to form corresponding diesters
US9850194B2 (en) 2015-12-16 2017-12-26 Evonik Degussa Gmbh Process for double carbonylation of allyl alcohols to corresponding diesters
US10807934B1 (en) 2019-05-31 2020-10-20 Lyondell Chemical Technology, L.P. High linear selectivity ligand for allyl alcohol hydroformylation
WO2020242977A1 (en) * 2019-05-31 2020-12-03 Lyondell Chemical Technology, L.P. High linear selectivity ligand for allyl alcohol hydroformylation
TWI738360B (en) * 2019-05-31 2021-09-01 美商利安德化學科技有限公司 High linear selectivity ligand for allyl alcohol hydroformylation and process to produce 4-hydroxybutyraldehyde

Also Published As

Publication number Publication date
EP2714699A1 (en) 2014-04-09
WO2012163837A1 (en) 2012-12-06
JP2014520089A (en) 2014-08-21
CA2835744A1 (en) 2012-12-06
BR112013030262A2 (en) 2016-12-06
TW201306939A (en) 2013-02-16
US8791305B2 (en) 2014-07-29
CN103748102A (en) 2014-04-23
CN103562213A (en) 2014-02-05
US9108912B2 (en) 2015-08-18
RU2013157751A (en) 2015-07-10
US20140114090A1 (en) 2014-04-24
JP2014524889A (en) 2014-09-25
BR112013029852A2 (en) 2016-12-20
US20140243558A1 (en) 2014-08-28
EP2714700A1 (en) 2014-04-09

Similar Documents

Publication Publication Date Title
US9108912B2 (en) Hydroformylation process
US7294602B1 (en) Hydroformylation process
EP2081882B1 (en) Hydroformylation process
EP2429978B1 (en) Hydroformylation process
EP3976625B1 (en) High linear selectivity ligand for allyl alcohol hydroformylation
US11613510B2 (en) Methylcyclohexane as allyl alcohol hydroformylation solvent
JP2014508124A (en) Method for Telomerization of Butadiene Using Mono-Orthoalkoxy Substitution Catalyst
DE102011102666A1 (en) Producing 4-hydroxybutyraldehyde, comprises reacting allyl alcohol with carbon monoxide and hydrogen in polar solvent, in presence of catalytic system, which is formed from rhodium complex and cyclobutane ligand

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12723505

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014511904

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012723505

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013030262

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 14122153

Country of ref document: US

ENP Entry into the national phase

Ref document number: 112013030262

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131126